Leerink Swann on DUSA Pharmaceuticals (DUSA): An Unusual Small Cap Opportunity; Steady, Profitable Growth in a Large Market
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
| Dusa Pharmaceuticals, Inc. (NYSE: DUSA) | Delayed: 56.68 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $56.68 | 52 Week High | $8.01 | |||
| Open | $56.68 | 52 Week Low | $4.10 | |||
| Day High | $56.68 | P/E | 472.33 | |||
| Day Low | $56.68 | EPS | $0.12 | |||
| Volume | 10 | |||||
